Monday, February 24, 2014

Dr. Yancy on Recent Heart Failure Studies

Dr. Melissa Walton-Shirley interviews Dr. Clyde Yancy on TOPCAT and ROSE-AHF, and what the future holds for heart failure therapies.

theheart.org on Medscape

via Medscape news

High potency statins linked to better outcome following a heart attack

A study looking at the data of thousands of patients who suffered heart attacks has suggested treatment with high-potency statins offers a significantly improved chance of survival compared to those taking normal statins.

via Medical News Today

Important step towards pharmaceutical-based therapies that regenerate heart muscle

The power of regenerative medicine appears to have turned science fiction into scientific reality - by allowing scientists to transform skin cells into cells that closely resemble beating heart cells. However, the methods required are complex, and the transformation is often incomplete.

via Medical News Today

10 of 11 new gene signals are likely drug targets for hypertension

A large international study analyzing genes in tens of thousands of individuals has discovered 11 new genetic signals associated with blood pressure levels. Ten of those signals are in or very near genes encoding proteins that appear to be likely targets for drugs already in existence or in development.

via Medical News Today